عرض بسيط للتسجيلة

المؤلفYakti, Fatima A.
المؤلفAbusalah, Lana
المؤلفGanji, Vijay
تاريخ الإتاحة2024-07-22T09:19:59Z
تاريخ النشر2024
اسم المنشورLife
المصدرScopus
المعرّفhttp://dx.doi.org/10.3390/life14010024
الرقم المعياري الدولي للكتاب20751729
معرّف المصادر الموحدhttp://hdl.handle.net/10576/56910
الملخصCOVID-19 can manifest as either asymptomatic or progressing to a severe phase in some patients, which may require hospitalization. These patients may experience dyspnea and hypoxia, leading to the development of acute respiratory distress syndrome. Studies have reported an increased risk of severe sarcopenia in COVID-19 patients during and after recovery. This narrative review aimed to summarize and synthesize available studies on the association between sarcopenia and mortality in critically ill COVID-19 patients. A total of 22 studies conducted on hospitalized COVID-19 patients were included in this review. Of those, 17 studies reported a direct association, while 5 studies showed no association between sarcopenia and mortality in severe COVID-19 patients. It is important to maintain muscle quality and quantity in defense against COVID-19. The measurement of lean muscle mass should be included in the risk assessment of severely ill COVID-19 patients as part of the therapy plan.
اللغةen
الناشرMultidisciplinary Digital Publishing Institute (MDPI)
الموضوعcoronavirus
COVID-19
elderly
mortality
muscle mass
sarcopenia
SARS-CoV-2
العنوانSarcopenia and Mortality in Critically Ill COVID-19 Patients
النوعArticle Review
رقم العدد1
رقم المجلد14
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة